Mode
Text Size
Log in / Sign up
N/A N=44 Randomized Single-blind Treatment

Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders

Autism · Autism Spectrum Disorder · Autistic Disorder · Asperger Syndrome · Pervasive Developmental Disorder

Enrolled (actual)
44
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcome: Primary: Reduction in Social Responsiveness Scale, Second Edition (SRS-2) - Adult (Relative/Other Report) — 68.67; 70.41; 66.08; 72.33 Scaled Score — p=.006

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Training to Understand and Navigate Emotions and Interactions (TUNE In) (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Pennsylvania
Primary completion
Jun 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Reduction in Social Responsiveness Scale, Second Edition (SRS-2) - Adult (Relative/Other Report)
68.67; 70.41; 66.08; 72.33 .006 sig

Summary

The purpose of this study is to test a novel, three-part cognitive behavioral treatment strategy to improve social functioning in adults with autism spectrum disorder. The treatment, named TUNE In (Training to Understand and Navigate Emotions and Interactions), includes components to address the many behavioral domains involved in social functioning, including social motivation, social anxiety, social cognition, social skills, and generalization of the skills to community settings. The Investigators will test the efficacy of TUNE In to improve social functioning in adults with autism spectrum disorder (ASD), using a randomized controlled trial using the SRS-2 as the primary outcome measure.

Eligibility Criteria

Inclusion Criteria

  • diagnosis of autism spectrum disorder

Exclusion Criteria

  • intellectual disability
  • severe mood or psychotic symptoms experienced in the past 4 weeks
  • severe self-injurious or aggressive behavior
  • severe extrapyramidal motor or sedating side effects of medications
  • concomitant participation in another social skills treatment program.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04788537). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search